Joseph Leach, MD:
As senior vice president and chief medical officer (CMO) at Prime Therapeutics, Joseph Leach, M.D., is responsible for providing clinical leadership and expertise to the enterprise, informing and influencing internal and external stakeholders about Prime’s specialty and total drug management capabilities, contributing to innovation in these capabilities and driving client growth.
Dr. Leach joined Prime with more than 20 years of experience as a clinician, researcher and health care leader. For the past 10 years, Dr. Leach has been a hematologist and medical oncologist with Minnesota Oncology, where he continues to see patients. Active in clinical research, Dr. Leach has held numerous national leadership positions in research, including service on the National Cancer Institute Thoracic Malignancy Steering Committee and several roles with the Eastern Cooperative Oncology Group, which was one of the first publicly funded cooperative groups to perform multi-center clinical trials for cancer research.
Prior to joining Minnesota Oncology, Dr. Leach practiced oncology and held physician leadership roles at several Minnesota hospitals, including the Virginia Piper Cancer Institute at Abbott Northwestern Hospital in Minneapolis, Methodist Hospital in St. Louis Park and St. Francis Regional Medical Center in Shakopee.
Dr. Leach earned a bachelor’s degree in biology from St. Olaf College in Northfield, Minnesota, and his Doctor of Medicine degree from the University of Minnesota. He trained in internal medicine and medical oncology at the University of Oklahoma, Oklahoma City, Oklahoma.
Midwest Lung Cancer Patient Summit Presentation:
Clinical Trials: Promising Treatments Being Developed Today – Joseph Leach, MD, Senior Vice President and Chief Medical Officer, Prime Therapeutics LLC